UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis

König, JC; Karsay, R; Gerß, J; Schlingmann, KP; Dahmer-Heath, M; Telgmann, AK; Kollmann, S; ... Schlevogt, B; + view all (2022) Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis. Kidney International Reports 10.1016/j.ekir.2022.05.035. (In press). Green open access

[thumbnail of 1-s2.0-S2468024922014371-main.pdf]
Preview
Text
1-s2.0-S2468024922014371-main.pdf - Published Version

Download (1MB) | Preview

Abstract

Introduction: Nephronophthisis (NPH) comprises a group of rare disorders accounting for up to 10% of end-stage kidney disease (ESKD) in children. Prediction of kidney prognosis poses a major challenge. We assessed differences in kidney survival, impact of variant type, and the association of clinical characteristics with declining kidney function. Methods: Data was obtained from 3 independent sources, namely the network for early onset cystic kidney diseases clinical registry (n = 105), an online survey sent out to the European Reference Network for Rare Kidney Diseases (n = 60), and a literature search (n = 218). Results: A total of 383 individuals were available for analysis: 116 NPHP1, 101 NPHP3, 81 NPHP4 and 85 NPHP11/TMEM67 patients. Kidney survival differed between the 4 cohorts with a highly variable median age at onset of ESKD as follows: NPHP3, 4.0 years (interquartile range 0.3–12.0); NPHP1, 13.5 years (interquartile range 10.5–16.5); NPHP4, 16.0 years (interquartile range 11.0–25.0); and NPHP11/TMEM67, 19.0 years (interquartile range 8.7–28.0). Kidney survival was significantly associated with the underlying variant type for NPHP1, NPHP3, and NPHP4. Multivariate analysis for the NPHP1 cohort revealed growth retardation (hazard ratio 3.5) and angiotensin-converting enzyme inhibitor (ACEI) treatment (hazard ratio 2.8) as 2 independent factors associated with an earlier onset of ESKD, whereas arterial hypertension was linked to an accelerated glomerular filtration rate (GFR) decline. Conclusion: The presented data will enable clinicians to better estimate kidney prognosis of distinct patients with NPH and thereby allow personalized counseling.

Type: Article
Title: Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.ekir.2022.05.035
Publisher version: https://doi.org/10.1016/j.ekir.2022.05.035
Language: English
Additional information: © 2022 International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BYNC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: end-stage kidney disease; genetic variant severity; genotype-phenotype correlations; kidney survival; nephronophthisis; prognostic factors
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/10154002
Downloads since deposit
36Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item